Edwards Lifesciences
EW
85.78
-0.70
-0.81%
Edwards Lifesciences
US · EW
#442 by market cap
Listed 1970
85.78
-0.70
-0.81%
Live - 5344 symbols - heartbeat 386s ago
· 2026-10-08 07:37
Pre-market
85.78
0.00%
After-hours
85.78
0.00%
- Market cap
- 49.44B
- P/E (TTM)i
- 49.87
- P/Bi
- 4.66
- EPSi
- 1.83
- Div yieldi
- 0.00%
- 52W posi
- 56%
Reader sentiment
Are you bullish or bearish on EW?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 17 analysts
Buy
Avg price target
103.40 +20.5%
Price target rangecurrent 85.78
Low85.00
Avg103.40
High110.00
Buy 82%
Hold 18%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-28 | Leerink Partners | -- | BUY | 101.00 |
| 2026-09-21 | Piper Sandler | -- | BUY | 101.00 |
| 2026-09-11 | Jefferies | -- | BUY | 105.00 |
| 2026-09-10 | William Blair | -- | BUY | -- |
| 2026-09-10 | BTIG | -- | BUY | 110.00 |
| 2026-09-10 | Citi | -- | BUY | 110.00 |
| 2026-09-02 | William Blair | -- | BUY | -- |
| 2026-08-18 | William Blair | -- | BUY | -- |
| 2026-08-13 | Citi | -- | BUY | 110.00 |
| 2026-07-28 | UBS | -- | BUY | 110.00 |
| 2026-07-28 | J.P. Morgan | -- | BUY | 105.00 |
| 2026-07-24 | William Blair | -- | BUY | -- |
| 2026-07-24 | Piper Sandler | -- | BUY | 101.00 |
| 2026-07-24 | BTIG | -- | BUY | 110.00 |
| 2026-07-24 | Truist Financial | -- | HOLD | 95.00 |
| 2026-07-24 | Stifel | -- | BUY | 110.00 |
| 2026-07-24 | Leerink Partners | -- | BUY | 101.00 |
| 2026-07-24 | Oppenheimer | -- | HOLD | -- |
| 2026-07-24 | J.P. Morgan | -- | BUY | 105.00 |
| 2026-07-23 | TD Cowen | -- | BUY | 104.00 |
| 2026-07-23 | CCORF | -- | HOLD | 85.00 |
| 2026-07-23 | RBC Capital | -- | BUY | 110.00 |
| 2026-07-21 | TD Cowen | -- | BUY | 104.00 |
| 2026-07-21 | BofA Securities | -- | BUY | 100.00 |
| 2026-07-16 | Truist Financial | -- | HOLD | 95.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
5
■ Upgrades■ Downgrades
- 5 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: UBS moved from Hold to Buy on 2026-07-28.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-28 | UBS | HOLD → BUY | 110.00 |
| 2026-07-24 | Leerink Partners | HOLD → BUY | 101.00 |
| 2026-04-01 | Wolfe Research | HOLD → BUY | 92.00 |
| 2026-01-09 | TD Cowen | HOLD → BUY | 97.00 |
| 2025-12-18 | J.P. Morgan | HOLD → BUY | 100.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-23 | After close | ±9.52% | -1.42% (in line) |
| 2026/Q1 | 2026-04-23 | After close | ±8.75% | +5.56% (in line) |
| 2025/Q4 | 2026-02-10 | After close | ±7.19% | +2.96% (in line) |
| 2025/Q3 | 2025-10-30 | After close | ±6.57% | -1.23% (in line) |
| 2025/Q2 | 2025-07-24 | After close | ±9.50% | +5.54% (in line) |
| 2025/Q1 | 2025-04-23 | After close | ±9.96% | +6.63% (in line) |
| 2024/Q4 | 2025-02-11 | After close | ±7.44% | +6.92% (in line) |
| 2024/Q3 | 2024-10-24 | After close | ±11.16% | -1.38% (in line) |
| 2024/Q2 | 2024-07-24 | After close | ±7.87% | -31.34% (beat) |
| 2024/Q1 | 2024-04-25 | After close | ±7.76% | -1.80% (in line) |
| 2023/Q4 | 2024-02-06 | After close | ±7.62% | -1.86% (in line) |
| 2023/Q3 | 2023-10-25 | After close | ±11.03% | -8.14% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:37:40 · For reference only, not investment advice and not tailored to your situation.